{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-111706","form_type":"8-K","ticker":"DMII","cik":"0002040475","company_name":"Drugs Made In America Acquisition II Corp.","filed_at":"2025-11-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.436327+00:00","generated_at":"2026-05-16T18:56:49.524951+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Drugs Made In America Acquisition II Corp. appoints Saleem Elmasri as CFO after Glenn Worman resigns","bullets":["Glenn Worman resigned as CFO and principal financial and accounting officer effective October 8, 2025, with no disagreement with the company.","Saleem Elmasri was appointed CFO effective November 17, 2025, under a consulting agreement with Titan Advisory Services LLC.","Compensation includes $42,000 per year ($3,500 per month) plus 100,000 ordinary shares transferred by CEO Lynn Stockwell.","Elmasri is a CPA with 20 years experience, previously at PwC and as Managing Partner of Titan Advisory Services LLC since 2020."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-111706","json":"https://secwatch.observer/filing/0001213900-25-111706.json","markdown":"https://secwatch.observer/filing/0001213900-25-111706.md","text":"https://secwatch.observer/filing/0001213900-25-111706.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025111706/0001213900-25-111706-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025111706/ea0265998-8k_drugs2.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-16T18:56:49.524951+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}